A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent.

Prostate Cancer UK's Big Golf Race. Prostate Cancer UK is calling on golfers across the UK to help fund life-saving projects.

Mateship, support, information: this and more are what two cancer survivors are hopeful a dedicated prostate cancer nurse can ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest evidence yet that a shorter ...

Prostate cancer is a serious health problem for men around the world. Doctors know that things like being overweight, having ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

Currently, doctors usually check PSA levels about six to eight weeks after surgery. However, a new study from Mass General ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.